White label – Pompe disease - ClinicalTrials.eu

Study of Durvalumab with Chemoradiation Therapy for Patients with Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma

Not recruiting

3 1 1
Investigated Diseases:
- Oesophageal squamous cell carcinoma
Investigated Drugs:
Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

Not recruiting

3 1 1
Investigated Diseases:
- Hypertension
Investigated Drugs:
- Lorundrostat
- Tetracosactide
+2
Study on the Safety and Effectiveness of Ibrutinib for Children and Young Adults with Chronic Graft Versus Host Disease

Not recruiting

1 1 1 1
Investigated Diseases:
- Chronic graft versus host disease
Investigated Drugs:
- Ibrutinib
- Prednisone
Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Not recruiting

3 1 1 1
Investigated Drugs:
+10
Study of Abemaciclib with Irinotecan and Temozolomide for Children and Young Adults with Relapsed or Refractory Solid Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
Study on Eptinezumab for Preventing Chronic Migraine in Adults

Not recruiting

3 1 1 1
Investigated Diseases:
- Migraine
Investigated Drugs:
- Eptinezumab
Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
- Follicle centre lymphoma follicular grade I II – III refractory
Investigated Drugs:
+8
Study on Esomeprazole Magnesium for Maintaining Healing of Erosive Esophagitis in Children Aged 1 to 11 Years

Not recruiting

3 1 1 1
Investigated Diseases:
- Erosive oesophagitis
Investigated Drugs:
- Esomeprazole Magnesium
Study Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes

Not recruiting

3 1 1 1
Investigated Diseases:
- Transitional cell carcinoma
Investigated Drugs:
Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

Not recruiting

2 1
Investigated Diseases:
- Amyotrophic lateral sclerosis
Investigated Drugs:
- Utreloxastat
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies